Immune tolerance induction in the era of emicizumab - still the first choice for patients with hemophilia A and inhibitors
Speaker(s): Dr. Katharina Holstein
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the latest in research, breakthrough developments, and more.
The National Hemophilia Foundation is dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy, and research.
Learn More at: www.hemophilia...
Негізгі бет Immune tolerance induction in the era of emicizumab
No video
Пікірлер